Vor Biopharma VOR Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Vor Biopharma in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vor Biopharma's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vor Biopharma's financing cash flow?
- Vor Biopharma (VOR) reported financing cash flow of $74.87M in Q1 2026.
- How has Vor Biopharma's financing cash flow changed year-over-year?
- Vor Biopharma's financing cash flow increased by 12454.8% year-over-year, from -$606K to $74.87M.
- What is the long-term trend for Vor Biopharma's financing cash flow?
- Over 4 years (2021 to 2025), Vor Biopharma's financing cash flow has grown at a 21.2% compound annual growth rate (CAGR), from $233.36M to $503.81M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.